scholarly journals Human scavenger receptor class B type II (SR-BII) and cellular cholesterol efflux

2004 ◽  
Vol 377 (3) ◽  
pp. 741-747 ◽  
Author(s):  
Jane V. MULCAHY ◽  
Dave R. RIDDELL ◽  
James S. OWEN

Although studies in recombinant cells indicate that scavenger receptor class B, type I (SR-BI) can promote cholesterol efflux, investigations in transgenic mice overexpressing or deficient in SR-BI endorse its physiological function as selectively sequestering cholesteryl esters from high-density lipoproteins (HDLs). Less clear is the role of SR-BII, a splice variant of the SR-B gene that differs only in the C-terminal cytoplasmic domain. Here, we identify several putative signalling motifs in the C-terminus of human SR-BII, which are absent from SR-BI, and hypothesize that these motifs interact with signalling molecules to mobilize stored cholesteryl esters and/or promote the efflux of intracellular free cholesterol. ‘Pull-down’ assays using a panel of tagged SH3 (Src homology 3) domains showed that cytoplasmic SR-BII, but not cytoplasmic SR-BI, bound the SH3 domain of phospholipase C-γ1; this interaction was not, however, detected under more physiological conditions. Specific anti-peptide antisera identified SR-BII in human monocyte/macrophage THP-1 cells and, in recombinant cells, revealed receptor localization to caveolae, a plasma membrane microdomain that concentrates signal-transducer molecules and acts as a conduit for cholesterol flux between cells and lipoproteins. Consistent with its caveolar localization, expression of human SR-BII in recombinant Chinese hamster ovary cells (CHO–SR-BII) was associated with increased HDL-mediated cholesterol efflux. Nevertheless, when CHO-SR-BII cells were pre-loaded with cholesteryl [3H]oleate and incubated with HDL, cholesteryl ester stores were not reduced compared with control cells. We conclude that although human SR-BII is expressed by macrophages, contains cytoplasmic signalling motifs and localizes to caveolae, its ability to stimulate cholesterol efflux does not reflect enhanced hydrolysis of stored cholesteryl esters.

2020 ◽  
Author(s):  
Xiangyi Cao ◽  
Qiong Kang ◽  
Deng Jiang ◽  
Jun Xiao ◽  
Yanyu Zhang ◽  
...  

Abstract Background: Hepatitis C virus is the major cause of chronic hepatitis which may deteriorate into liver cirrhosis or hepatocellular carcinoma. A number of studies have demonstrated that HCV cell entry is a complex multi-step process involving several cellular proteins, such as scavenger receptor class B type I (SR-BI), tetraspanin CD81, tight junction protein claudin-1 (CLDN-1) and occludin (OCLN). The low-density lipoprotein receptor (LDLR) is an important factor during the initial HCV particle-binding step, which interacts with the complex formed between the virus particle and the lipoprotein in the blood. However, the process of HCV early infection is not well-established, with many details remaining to be elucidated.This research aimed to study the early entry stage of HCV virus particles and the role of LDLR more effectively.Methods: Recombinant murine cell models of HCV infection in vitro was constructed, that expressed human HCV receptors, such as LDLR, CD81, SR BI, CLDN-1, and OCLN. These factors were also introduced to mice by hydrodynamic delivery to construct a humanized mouse model of HCV infection in vivo.Expression levels of the mRNA of HCV entry factors in recombinant cells were measured by qRT-PCR.Western blotting was used to determine whether the recombinant cells successfully expressed cellular proteins. HCV RNA was assayed by q-PCR following the incublation of HCVsd and HCVcc with the transgenice.Results: Transgenic murine cell lines and mice were developed successfully, and expressed four or five human HCV entry factors in tandem or individually, respectively. We found that all of these transgenic cells and mice were susceptible to HCV, and five entry factors (5EF) rendered higher infectivity. Additionally, we observed that four entry factors (4EF/hLDLR-) could facilitate abundant HCV entry, but four other factors (4EF/hSR-BI-) were less effective.Conclusions: Whether in vitro or in vivo, SR-BI is an essential factor in HCV invasion, and target cells and mice were more vulnerable to the virus in the presence of SR-BI than LDLR. These results suggested that SR-BI may be a potential drug target to inhibit HCV early infection, and the absence of LDLR could reduce the infectivity to the virus.


FEBS Journal ◽  
2010 ◽  
Vol 277 (18) ◽  
pp. 3780-3788 ◽  
Author(s):  
Tao Yang ◽  
Caihong Chen ◽  
Bin Zhang ◽  
He Huang ◽  
Ganqiu Wu ◽  
...  

2010 ◽  
Vol 30 (11) ◽  
pp. 2121-2127 ◽  
Author(s):  
Richard W. James ◽  
Marie-Claude Brulhart-Meynet ◽  
Anurag Kumar Singh ◽  
Brigitte Riederer ◽  
Ursula Seidler ◽  
...  

1999 ◽  
Vol 274 (29) ◽  
pp. 20344-20350 ◽  
Author(s):  
Wendi V. Rodrigueza ◽  
Stephen T. Thuahnai ◽  
Ryan E. Temel ◽  
Sissel Lund-Katz ◽  
Michael C. Phillips ◽  
...  

Diabetes ◽  
2017 ◽  
Vol 66 (4) ◽  
pp. 1097.2-1097
Author(s):  
Joanne T.M. Tan ◽  
Hamish C.G. Prosser ◽  
Louise L. Dunn ◽  
Laura Z. Vanags ◽  
Anisyah Ridiandries ◽  
...  

1998 ◽  
Vol 273 (10) ◽  
pp. 5599-5606 ◽  
Author(s):  
Bo Jian ◽  
Margarita de la Llera-Moya ◽  
Yong Ji ◽  
Nan Wang ◽  
Michael C. Phillips ◽  
...  

Diabetes ◽  
2016 ◽  
Vol 65 (10) ◽  
pp. 3091-3103 ◽  
Author(s):  
Joanne T.M. Tan ◽  
Hamish C.G. Prosser ◽  
Louise L. Dunn ◽  
Laura Z. Vanags ◽  
Anisyah Ridiandries ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document